Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$872M |
| 2 |
Microsoft
MSFT
|
$324M |
| 3 |
Intuit
INTU
|
$313M |
| 4 |
PTC
PTC
|
$289M |
| 5 |
Amazon
AMZN
|
$286M |
Top Sells
| 1 |
Linde
LIN
|
$575M |
| 2 |
Booking.com
BKNG
|
$570M |
| 3 |
Meta Platforms (Facebook)
META
|
$538M |
| 4 |
NVIDIA
NVDA
|
$455M |
| 5 |
Salesforce
CRM
|
$401M |
Sector Composition
| 1 | Technology | 32.54% |
| 2 | Healthcare | 19.02% |
| 3 | Financials | 11.15% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Texas Instruments
TXN
$171B
| $134M | 0.07% |
759,903
-264,992
| -26% | -$46.7M |
|
227
Janux Therapeutics
JANX
$1.44B
| $134M | 0.07% |
4,598,092
+1,035,690
| +29% | +$30.1M |
|
228
iShares Core S&P 500 ETF
IVV
$664B
| $132M | 0.07% |
236,859
+27,690
| +13% | +$15.5M |
|
229
Williams Companies
WMB
$69.9B
| $132M | 0.07% |
2,230,132
+35,730
| +2% | +$2.12M |
|
230
Blackbaud
BLKB
$3.23B
| $132M | 0.07% |
2,121,238
-763,824
| -26% | -$47.4M |
|
231
Align Technology
ALGN
$10.1B
| $130M | 0.07% |
815,008
+664,039
| +440% | +$106M |
|
232
Cencora
COR
$56.7B
| $129M | 0.07% |
468,383
+99,713
| +27% | +$27.4M |
|
233
Digital Realty Trust
DLR
$55.7B
| $127M | 0.07% |
894,644
+787,820
| +737% | +$112M |
|
234
Mirion Technologies
MIR
$5.28B
| $126M | 0.07% |
8,587,664
+257,169
| +3% | +$3.76M |
|
235
Ardelyx
ARDX
$1.57B
| $123M | 0.07% |
24,977,006
+589,065
| +2% | +$2.9M |
|
236
Edgewise Therapeutics
EWTX
$1.64B
| $123M | 0.07% |
5,282,154
+298,214
| +6% | +$6.94M |
|
237
United Parcel Service
UPS
$72.1B
| $122M | 0.07% |
1,116,376
-6,510
| -0.6% | -$714K |
|
238
ITT
ITT
$13.3B
| $122M | 0.07% |
945,484
+17,368
| +2% | +$2.24M |
|
239
Insmed
INSM
$30.7B
| $121M | 0.07% |
1,545,419
+99,723
| +7% | +$7.78M |
|
240
Crown Holdings
CCK
$11B
| $120M | 0.07% |
1,361,464
-682,919
| -33% | -$60.2M |
|
241
Crinetics Pharmaceuticals
CRNX
$3.35B
| $119M | 0.07% |
3,424,442
+629,001
| +23% | +$21.8M |
|
242
Dyne Therapeutics
DYN
$2.02B
| $118M | 0.06% |
10,353,416
+2,974,107
| +40% | +$34M |
|
243
Snowflake
SNOW
$75.3B
| $118M | 0.06% |
783,546
+393,790
| +101% | +$59.3M |
|
244
Elevance Health
ELV
$70.6B
| $118M | 0.06% |
272,772
-90,754
| -25% | -$39.2M |
|
245
Marriott International Class A Common Stock
MAR
$71.9B
| $116M | 0.06% |
489,132
+19,893
| +4% | +$4.71M |
|
246
Guidewire Software
GWRE
$22B
| $116M | 0.06% |
617,260
+61,368
| +11% | +$11.5M |
|
247
Xenon Pharmaceuticals
XENE
$3.02B
| $114M | 0.06% |
3,325,093
+458,338
| +16% | +$15.7M |
|
|
248
Linde
LIN
$220B
| $114M | 0.06% |
247,648
-1,251,705
| -83% | -$575M |
|
249
Coca-Cola
KO
$292B
| $113M | 0.06% |
1,599,567
-7,734
| -0.5% | -$544K |
|
250
Sportradar
SRAD
$9.14B
| $112M | 0.06% |
5,092,744
+2,071,533
| +69% | +$45.5M |
|